Interactive Microscopy: April 11-13, 2018


April 11, 2018 to April 13, 2018
USCAP Interactive Center, Palm Springs, CA

Interactive Microscopy: April 11-13, 2018
Megan S. Lim

Megan S. Lim, M.D., Ph.D.
Hospital of the University of Pennsylvania / Children’s Hospital of Philadelphia

Course Director

Dr. Lim is the Director of the Joint Division of Hematopathology, Hospital of the University of Pennsylvania and the Children's Hospital of Philadelphia in the Department of Pathology and Laboratory Medicine, Director of the Hematopathology Fellowship Program, Interim Director of the Clinical Flow Cytometry Laboratory, and the Director of the Lymphoma Biology Program at the Abramson Cancer Center.

Dr. Lim received an M.D. from the University of Calgary and a Ph.D. in Molecular Oncology from the University of Calgary and National Cancer Institute Lab of Pathology jointly. Dr. Lim obtained her Hematopathology fellowship training at the National Cancer Institute after which she assumed a faculty position at the University of Toronto (1998-2000), the University of Utah (2000-2006), and the University of Michigan (2000-2015) before moving to the University of Pennsylvania in 2015. She has held numerous leadership positions and served on training and education committees for the Association for Molecular Pathology and the United States and Canadian Academy of Pathology. She is the Vice-Chair of the Non-Hodgkin Lymphoma Disease Committee of the Children’s Oncology Group and participates in integrated translational research in pediatric lymphoma. Her research interests are focused on elucidating mechanisms involved in lymphoma pathogenesis. She has participated and directed numerous CME activities for AMP, ASCP, CAP, and USCAP.

Nathanael Bailey

Nathanael Bailey, M.D.
University of Pittsburgh Medical Center

Dr. Bailey is an Associate Professor of Pathology in the Division of Hematopathology at the University of Pittsburgh Medical Center. Prior to joining UPMC, he was an Assistant Professor at the University of Michigan, where he also directed the Molecular Genetic Pathology Fellowship Program. Dr. Bailey trained in molecular genetic pathology at the University of Michigan after completing an hematopathology fellowship and anatomic and clinical pathology residency training at West Virginia University. Dr. Bailey has coauthored numerous manuscripts, review articles, and book chapters on the molecular basis of hematolymphoid neoplasms. Dr. Bailey is especially interested in pathology education and has been awarded for his resident teaching. He has spoken at several regional and national meetings and is active in the United States and Canadian Academy of Pathology, the Association for Molecular Pathology, and the Society for Hematopathology.

Kojo S. J. Elenitoba-Johnson

Kojo S. J. Elenitoba-Johnson, M.D.
Perelman School of Medicine, University of Pennsylvania

Dr. Elenitoba-Johnson is the Peter C. Nowell, M.D., Professor and Founding Director of the Penn Center for Personalized Diagnostics, and Founding Director of the Division of Precision and Computational Diagnostics at the Perelman School of Medicine at the University of Pennsylvania.

Dr. Elenitoba-Johnson earned his M.D. from the College of Medicine, University of Lagos in Lagos, Nigeria. He has board certification in AP/CP, hematopathology and molecular genetic pathology. His research focuses on elucidating the pathogenesis of human malignant lymphomas and identifying biomarkers and therapeutic targets for lymphomas. Elenitoba-Johnson has been recognized with numerous awards, including the American Society of Investigative Pathology Scholarship in 1993; the Society for Hematopathology Pathologist in Training Award in 1998; and the Ramzi S. Cotran Young Investigator Award from the United States and Canadian Academy of Pathology in 2006. He is an elected member of the American Society for Clinical Investigation (2011), and is the recipient of the Outstanding Investigator Award given by the American Society for Investigative Pathology (2012). Dr. Elenitoba-Johnson is a member for the Board of Scientific Counselors of the National Cancer Institute of the National Institutes of Health. He currently serves as President-Elect of the Association for Molecular Pathology (AMP). He has authored more than 150 peer-reviewed research publications and has contributed over 20 book chapters.

L. Jeffrey Medeiros

L. Jeffrey Medeiros, M.D.
The University of Texas MD Anderson Cancer Center

Dr. Medeiros is Dr. Medeiros received his MD from the University of Massachusetts and did residency in Anatomic and Clinical Pathology at the New England Deaconess Hospital in Boston (now Beth Israel Deaconess Medical Center). He also completed four years of fellowship training: two years at Stanford University Medical Center (Surgical Pathology and Immunopathology), one year at Massachusetts General Hospital (Hematopathology), and one year at the National Cancer Institute (Hematopathology). His first job was a junior staff position at the National Cancer Institute. His first senior staff position was an Associate Professor of Pathology at Rhode Island Hospital/Brown University of School of Medicine, in Providence, Rhode Island. He subsequently was appointed Director of Hematopathology at City of Hope National Medical Center, in Duarte, California. In 1998, he joined the faculty at The University of Texas MD Anderson Cancer Center and he became the first Chair of the newly created Department of Hematopathology in 2002.

Dr. Medeiros is a member of the editorial boards of a number of journals including the American Journal of Clinical Pathology, American Journal of Surgical Pathology, Human Pathology, and Modern Pathology. He is co-author of three books: Ioachim’s Lymph Node Pathology (Lippincott Williams & Wilkins, 2007), Diagnostic Pathology: Lymph Nodes and Spleen with Extranodal Lymphomas (AMIRSYS, 2011), and Atlas of Lymph Node Pathology (Springer, 2013). Dr. Medeiros also has written a number of peer review publications.

His interests include the diagnosis of lymphomas, including the use of histologic, immunophenotypic and molecular methods for diagnosis and prognosis, and his recent research interests have focused on diffuse aggressive B-cell lymphomas.


view more